PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study Open Access
January 1, 2026
This review of patient-reported outcomes (PRO’s) monitoring on the POLARIX trial highlights the usefulness of this technology in our practice. We may see more of these systems in place in the future as more cellular therapy becomes available in the community setting.